Pfizer, as a publicly traded company, will eventually be required to disclose the details of its prescription drug pricing agreement with the White House under congressionally mandated securities law, but for now several industry analysts view the drug sales TrumpRx website alongside the agreement as mainly a self-promotional platform, with drugmakers effectively aiding President Donald Trump’s campaign for congressional Republicans ahead of the midterm elections.